AG
BPTH

Advisor Group’s Bio-Path Holdings Inc BPTH Stock Holding History

Advisor Group’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15
Closed -$4K – 5470
2019
Q2 		$4K Sell
15
-7
-32% -$2.22K ﹤0.01% 4800
2019
Q1 		$9K Buy
+22
New +$4.05K ﹤0.01% 4431

Other funds holding BPTH

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Advisor Group's BPTH Position: Q3 2019 in Review

Advisor Group sold out of Bio-Path Holdings Inc (BPTH) in Q3 2019, closing a stake of 15 shares — an estimated $4K sold.

Advisor Group first reported a position in BPTH in Q1 2019 and held it in 2 quarters. The position peaked at $9K in Q1 2019. 15 funds tracked by Wall St. Rank hold BPTH as of Q3 2019.

  • Advisor Group reported no remaining Bio-Path Holdings Inc position as of Q3 2019 after selling out during the quarter.
  • Advisor Group sold 15 Bio-Path Holdings Inc shares in Q3 2019, an estimated $4K.
  • Advisor Group first reported a position in Bio-Path Holdings Inc in Q1 2019 and held it in 2 quarters.
  • Advisor Group's Bio-Path Holdings Inc position peaked at $9K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q3 2019.

Based on Advisor Group's 13F filing for Q3 2019, filed 13 Nov 2019.